Johannes Leierer

5PUBLICATIONS
15CO-AUTHORS
Nutrigenomics and personalised nutritionPredictive and prognostic markersMolecular targetsPharmacogenomicsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 22, 2024
Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus.

Sara Denicolò, Vera Reinstadler, Felix Keller

|Jan 21, 2023
Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis.

Sara Denicolò, Viji Nair, Johannes Leierer

|Jul 02, 2021
Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease.

Johannes Leierer, Paul Perco, Benedikt Hofer

|Jun 02, 2021
Empagliflozin Inhibits IL-1β-Mediated Inflammatory Response in Human Proximal Tubular Cells.

Markus Pirklbauer, Sebastian Sallaberger, Petra Staudinger

|Sep 22, 2018
Guidelines and clinical practice at the primary level of healthcare in patients with type 2 diabetes mellitus with and without kidney disease in five European countries.

Susanne Eder, Johannes Leierer, Julia Kerschbaum

Pageof 1

Frequent Collaborators

3 joint publications

Paul Perco

2 joint publications

Gert Mayer

2 joint publications

Sara Denicolò

1 joint publications

Markus Pirklbauer